BC |
Breast cancer |
cGAS |
Cyclic GMP–AMP synthase |
CTLA4 |
Cytotoxic T-lymphocyte-associated protein 4 |
DCFDA |
2′,7′-Dichlorofluorescin diacetate |
DSS |
Disease-specific survival |
ETC |
Electron transport chain |
Evofos |
Evofosfamide |
HAP |
Hypoxia-associated prodrug |
HS |
Hypoxia score |
IFN |
Interferon |
IL-2 |
Interleukin 2 |
IS |
Immune score |
KIR2DL4 |
Killer Cell Immunoglobulin-Like Receptor, Two Ig Domains and Long Cytoplasmic Tail 4 |
OS |
Overall survival |
PCR |
Polymerase chain reaction |
PD1 |
Programmed death-1 |
ROS |
Reactive oxygen species |
STING |
Stimulator of Interferon Genes |
TME |
Tumor micro-environment |
TMRM |
Tetramethylrhodamine, methyl ester |